Skip to search formSkip to main contentSkip to account menu

tobanum

Known as: CLORANOLOL, chloranolol, 2-propanol, 1-(2,5-dichlorophenoxy)-3-((1,1-dimethylethyl)amino)- 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Adrenergic beta-AntagonistsAntihypertensive AgentsPropanolamines

Narrower (1)

GYKI-41099

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
[The comparative efficacy of nondrug and drug methods of treating hypertension].
Effectiveness of some physical therapeutic factors (constant magnetic field, impulse currents) and new hypotensive drugs (tobanum… 
1989
1989
Action of beta-adrenoceptor blockers on liver function of rats.
Three nonselective beta-adrenoceptor blockers, propranolol, cloranolol and talinolol, were examined in male rats. The amount and… 
1986
1986
[Clinical use of chloranolol (tobanum) in essential hypertension patients].
A clinical study of the efficiency of a new beta-blocker, chloranolol (Tobanum, Hungary), was carried out in 24 patients with… 
1985
1985
Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.
In a single blind clinical trial the effects of Tobanum (chloranolol), a beta-adrenergic receptor blocker, on 450 patients were… 
1985
1985
[Effect of tobanum on various functions of the heart in patients with ischemic heart disease and prospects for its clinical application].
In coronary patients with relatively intact myocardial function, tobanum increases physical stress tolerance and produces… 
1984
1984
Effects of beta-adrenergic inhibitors on noradrenaline and adrenaline metabolism in brain regions of the rat.
1981
1981
Specific and sensitive method for the determination of tobanum using gas chromatography with electron-capture and mass fragmentographic detection.
1980
1980
Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
The acute and chronic circulatory effects of a new beta adrenergic blocking drug, dl-1-(2,5-dichlorophenoxy)-3-tertiary… 
1980
1980
Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
1980
1980
Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
The electrophysiological properties of Tobanum (a new beta receptor blocking drug) were studied in 14 patients by the aid of His… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)